Siegfried Holding AG (SWX:SFZN)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 3.12B -6.9% |
| Revenue (ttm) | 1.34B +3.6% |
| Net Income | 171.35M +11.5% |
| EPS | 3.90 +11.2% |
| Shares Out | 43.81M |
| PE Ratio | 18.27 |
| Forward PE | 16.14 |
| Dividend | 0.40 (0.56%) |
| Ex-Dividend Date | Apr 28, 2026 |
| Volume | 85,225 |
| Open | 71.55 |
| Previous Close | 71.40 |
| Day's Range | 71.05 - 72.00 |
| 52-Week Range | 65.05 - 101.60 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 99.42 (+39.54%) |
| Earnings Date | Feb 19, 2027 |
About Siegfried Holding AG
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,... [Read more]
Full Company ProfileFinancial Performance
In 2025, Siegfried Holding AG's revenue was 1.33 billion, an increase of 2.57% compared to the previous year's 1.29 billion. Earnings were 168.66 million, an increase of 5.37%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for SFZN stock is "Buy." The 12-month stock price target is CHF 99.42, which is an increase of 39.54% from the latest price.
News
Siegfried Holding AG Earnings Call Transcript: H1 2026
Net sales grew 4.8% in local currencies and core EBITDA margin rose to 22.4% in H1 2026, with strong integration of recent acquisitions and robust progress on the EVOLVE+ strategy. Guidance for high single-digit growth and EBITDA margin above 23% is reaffirmed.
Siegfried Holding AG Quarterly report: H1 2026
Siegfried Holding AG has published its H1 2026 quarterly earnings report on August 21, 2026.
Siegfried Holding AG Slides: H1 2026
Siegfried Holding AG has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 21, 2026.
Siegfried Holding AG Earnings release: H1 2026
Siegfried Holding AG released its H1 2026 earnings on August 21, 2026, summarizing the period's financial results.
Siegfried upgraded to Buy from Hold at Stifel
Stifel upgraded Siegfried (SGFEF) to Buy from Hold with a price target of CHF 90, up from CHF 75. The firm believes the company’s expectations are reset, creating a lower…
Siegfried initiated with a Hold at Berenberg
Berenberg initiated coverage of Siegfried (SGFEF) with a Hold rating and CHF 77 price target The firm sees a lack of near-term visibility on Siegfried’s execution of ongoing projects and…
Siegfried downgraded to Neutral from Buy at UBS
UBS downgraded Siegfried (SGFEF) to Neutral from Buy with a price target of CHF 80, down from CHF 120. The firm sees 2026 being a “muted” organic growth year for…
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors a...
Siegfried price target raised to CHF 109 from CHF 105 at Deutsche Bank
Deutsche Bank analyst Fynn Scherzler raised the firm’s price target on Siegfried (SGFEF) to CHF 109 from CHF 105 and keeps a Buy rating on the shares. Published first on…
Siegfried price target lowered to CHF 96 from CHF 108 at RBC Capital
RBC Capital lowered the firm’s price target on Siegfried (SGFEF) to CHF 96 from CHF 108 and keeps a Sector Perform rating on the shares.
Siegfried Holding AG Earnings Call Transcript: H2 2025
Record profitability and margin expansion achieved in 2025, with 4.3% sales growth in local currency and strong cash generation. Strategic acquisitions and robust project inflow support a positive midterm outlook, despite currency headwinds and a pending large contract.
Siegfried Holding AG Annual report: H2 2025
Siegfried Holding AG has published its H2 2025 annual report on February 20, 2026.
Siegfried Holding AG Earnings release: H2 2025
Siegfried Holding AG released its H2 2025 earnings on February 20, 2026, summarizing the period's financial results.
Siegfried Holding AG Slides: H2 2025
Siegfried Holding AG has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 20, 2026.
Siegfried downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Siegfried (SGFEF) to Sector Perform from Outperform with a price target of CHF 108, up from CHF 105. The firm cites valuation for the downgrade following the…
Siegfried Holding AG Transcript: M&A announcement
The acquisition of three sites in the U.S. and Australia expands manufacturing capacity, strengthens supply chain resilience, and positions the company for growth in high-demand drug substance markets. The deal is value-accretive, margin accretive, and enables rapid integration with minimal CapEx.
Siegfried Holding AG Press release: M&A announcement
Siegfried Holding AG issued a press release on January 27, 2026, disclosing material business information to investors.
Siegfried Holding AG Slides: M&A announcement
Siegfried Holding AG has posted slides in relation to its latest quarterly earnings report, which was published on January 27, 2026.
Siegfried initiated with a Hold at Kepler Cheuvreux
Kepler Cheuvreux initiated coverage of Siegfried (SGFEF) with a Hold rating and CHF 92 price target The firm views the shares as fairly valued.
Siegfried initiated with an Outperform at William Blair
William Blair initiated coverage of Siegfried (SGFEF) with an Outperform rating and no price target The company produces solid returns in drug manufacturing but trades at a significant discount to…
Siegfried upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Charles Weston upgraded Siegfried (SGFEF) to Outperform from Sector Perform with a price target of CHF 105, down from CHF 108. The shares are now trading at…
Siegfried Holding AG Earnings Call Transcript: H1 2025
Solid H1 2025 results with 1.6% local currency sales growth, EBITDA margin up to 21.6%, and strong cash flow from networking capital optimization. Full-year guidance confirmed, with continued investment in technology, capacity, and selective M&A to drive above-market growth.
Siegfried Holding AG Quarterly report: H1 2025
Siegfried Holding AG has published its H1 2025 quarterly earnings report on August 21, 2025.
Siegfried Holding AG Slides: H1 2025
Siegfried Holding AG has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 21, 2025.
Siegfried downgraded to Add from Buy at Baader Helvea
Baader Helvea analyst Thomas Meyer downgraded Siegfried (SGFEF) to Add from Buy with a CHF 113.70 price target